Skip to content
Annika Bansal – Lifestyle
Author:
SK BIOSCIENCE
SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions
July 2, 2026
SK bioscience Joins Forces with Global Institutions to Advance Rotavirus Vaccine Development
June 9, 2026
SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access
June 2, 2026
SK bioscience Board Approves Financing Plan Supported by Korea Growth Fund
May 29, 2026
SK bioscience Signs Vaccine Technology Transfer Agreement with Colombia’s VECOL to Advance Local Vaccine Manufacturing in Latin America
May 26, 2026
SK bioscience Secures Funding to Advance RSV Preventive Antibody Development with RIGHT Foundation Support
March 18, 2026
SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union
March 5, 2026